In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: Distribution and radiosensitisation efficacy

Journal of Neuro-Oncology

Volumn 97, Issue 2, 2010, Pages 195-205

  Vinchon Petit, Sandrine ^a   Jarnet, Delphine ^c   Paillard, Archibald ^a   Benoit, Jean Pierre ^a   Garcion, Emmanuel ^a   Menei, Philippe ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c CENTRE PAUL PAPIN   (France)

Author keywords

Brain drug delivery; Nanomedicine; Nanoparticle uptake; Nanotechnology; Paclitaxel bioavailability; Radiochemotherapy

Indexed keywords

LABRAFAC; LIPID NANOCAPSULE; LIPOID; MACROGOL; MACROGOL HYDROXYSTEARATE; NANOCAPSULE; NANOCARRIER; PACLITAXEL; PHOSPHATIDYLCHOLINE; SOLUTOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VIVO STUDY; IRRADIATION; LIPOPHILICITY; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; RADIOSENSITIZATION; RAT; THERMODYNAMICS;

ANIMALS; BRAIN NEOPLASMS; CELL SEPARATION; COMBINED MODALITY THERAPY; CONVECTION; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; MICROSCOPY, CONFOCAL; NANOCAPSULES; NANOTECHNOLOGY; PACLITAXEL; RADIATION-SENSITIZING AGENTS; RATS; RATS, INBRED F344;

EID: 77950458133     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-0012-4     Document Type: Article

References (51)

1. De Angelis LM (2001) Brain tumors. N Engl J Med 344:114-123
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
3. Pardridge WM (2002) Drug and gene targeting to the brain with molecular Trojan horses. Nat Rev Drug Discov 1:131-139
4. Wang PP, Frazier J, Brem H (2002) Local drug delivery to the brain. Adv Drug Deliv Rev 54:987-1013
5. Kreuter J (2001) Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65-81
6. Tiwari SB, Amiji MM (2006) A review of nanocarrier-based CNS delivery systems. Curr Drug Deliv 3:219-232
7. Jain KK (2007) Use of nanoparticles for drug delivery in glio-blastoma multiforme. Expert Rev Neurother 7:363-372
8. Garcion E, Lamprecht A, Heurtault B, Paillard A, Aubert-Po-uessel A, Denizot B, Menei P, Benoit JP (2006) A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 5:1710-1722
9. Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP (2002) A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 19:875-880
10. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH (1994) Convection-enhanced delivery of macro-molecules in the brain. Proc Natl Acad Sci USA 91:2076-2080
11. Tishler RB, Geard CR, Hall EJ, Schiff PB (1992) Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52:3495-3497
12. Greenspan P, Mayer EP, Fowler SD (1985) Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol 100:965-973
13. Hed J, Hallden G, Johansson SG, Larsson P (1987) The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods 101: 119-125
14. Saini M, Bellinzona M, Meyer F, Cali G, Samii M (1999) Mor-phometrical characterization of two glioma models in the brain of immunocompetent and immunodeficient rats. J Neurooncol 42:59-67 (Pubitemid 29216790)
15. Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH (1999) Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 90:315-320
16. Lieberman DM, Laske DW, Morrison PF, Bankiewicz KS, Oldfield EH (1995) Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg 82:1021-1029
17. Mamot C, Nguyen JB, Pourdehnad M, Hadaczek P, Saito R, Bringas JR, Drummond DC, Hong K, Kirpotin DB, McKnight T, Berger MS, Park JW, Bankiewicz KS (2004) Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J Neurooncol 68:1-9 (Pubitemid 39137344)
18. MacKay JA, Deen DF, Szoka FC Jr (2005) Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. Brain Res 1035:139-153
19. Occhiogrosso G, Edgar MA, Sandberg DI, Souweidane MM (2003) Prolonged convection-enhanced delivery into the rat brainstem. Neurosurgery 52:388-393 (discussion 393-384 (Pubitemid 36159428)
20. Fleming AB, Saltzman WM (2002) Pharmacokinetics of the carmustine implant. Clin Pharmacokinet 41:403-419
21. Jordan MA, Toso RJ, Thrower D, Wilson L (1993) Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90:9552-9556
22. Glantz MJ, Choy H, Kearns CM, Mills PC, Wahlberg LU, Zuhowski EG, Calabresi P, Egorin MJ (1995) Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst 87:1077-1081
23. Fellner S, Bauer B, Miller DS, Schaffrik M, Fankhanel M, Spruss T, Bernhardt G, Graeff C, Farber L, Gschaidmeier H, Buschauer A, Fricker G (2002) Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest 110:1309-1318 (Pubitemid 35285757)
24. Cahan MA, Walter KA, Colvin OM, Brem H (1994) Cytotoxicity of taxol in vitro against human and rat malignant brain tumors. Cancer Chemother Pharmacol 33:441-444 (Pubitemid 24057699)
25. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48-58 (Pubitemid 37328807)
26. Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, Nass D, Hadani M, Ram Z (2004) Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg 100:472-479 (Pubitemid 38269075)
27. Noble CO, Krauze MT, Drummond DC, Yamashita Y, Saito R, Berger MS, Kirpotin DB, Bankiewicz KS, Park JW (2006) Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res 66:2801-2806
28. Yamashita Y, Krauze MT, Kawaguchi T, Noble CO, Drummond DC, Park JW, Bankiewicz KS (2007) Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubi-cin) in intracranial brain tumor xenografts. Neuro Oncol 9:20-28 (Pubitemid 46543485)
29. Saito R, Krauze MT, Noble CO, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS (2006) Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro Oncol 8:205-214 (Pubitemid 46542645)
30. Voges J, Reszka R, Gossmann A, Dittmar C, Richter R, Garlip G, Kracht L, Coenen HH, Sturm V, Wienhard K, Heiss WD, Jacobs AH (2003) Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann Neurol 54:479-487
31. Hadaczek P, Kohutnicka M, Krauze MT, Bringas J, Pivirotto P, Cunningham J, Bankiewicz K (2006) Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the stria-tum and transport of AAV2 within monkey brain. Hum Gene Ther 17:291-302
32. Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS (2004) Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 64:2572-2579
33. Neeves KB, Sawyer AJ, Foley CP, Saltzman WM, Olbricht WL (2007) Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles. Brain Res 1180:121-132
34. Heimberger AB, Archer GE, McLendon RE, Hulette C, Friedman AH, Friedman HS, Bigner DD, Sampson JH (2000) Temozolo-mide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats. Clin Cancer Res 6:4148-4153
35. Bruce JN, Falavigna A, Johnson JP, Hall JS, Birch BD, Yoon JT, Wu EX, Fine RL, Parsa AT (2000) Intracerebral clysis in a rat glioma model. Neurosurgery 46:683-691
36. Morrison PF, Lonser RR, Oldfield EH (2007) Convective delivery of glial cell line-derived neurotrophic factor in the human putamen. J Neurosurg 107:74-83
37. Lacoeuille F, Garcion E, Benoit JP, Lamprecht A (2007) Lipid nanocapsules for intracellular drug delivery of anticancer drugs. J Nanosci Nanotechnol 7:4612-4617
38. Vogelbaum MA (2005) Convection enhanced delivery for the treatment of malignant gliomas: symposium review. J Neuroon-col 73:57-69
39. Kaiser MG, Parsa AT, Fine RL, Hall JS, Chakrabarti I, Bruce JN (2000) Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model. Neuro-surgery 47:1391-1398 (discussion 1398-1399
40. Kroin JS, Penn RD (1982) Intracerebral chemotherapy: chronic microinfusion of cisplatin. Neurosurgery 10:349-354
41. Mardor Y, Roth Y, Lidar Z, Jonas T, Pfeffer R, Maier SE, Faibel M, Nass D, Hadani M, Orenstein A, Cohen JS, Ram Z (2001) Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 61:4971-4973
42. Popperl G, Goldbrunner R, Gildehaus FJ, Kreth FW, Tanner P, Holtmannspotter M, Tonn JC, Tatsch K (2005) O-(2-[18F]flu-oroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging 32:1018-1025 (Pubitemid 41339276)
43. Jin C, Bai L, Wu H, Tian F, Guo G (2007) Radiosensitization of paclitaxel, etanidazole and paclitaxel? etanidazole nanoparti-cles on hypoxic human tumor cells in vitro. Biomaterials 28:3724-3730 (Pubitemid 46855881)
44. Fountzilas G, Karavelis A, Capizzello A, Kalogera-Fountzila A, Karkavelas G, Zamboglou N, Selviaridis P, Foroglou G, Tour-kantonis A (1999) Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme. A phase II study. J Neurooncol 45:159-165 (Pubitemid 30197729)
45. Kortmann RD, Jeremic B, Weller M, Plasswilm L, Bamberg M (2003) Radiochemotherapy of malignant glioma in adults. Clinical experiences. Strahlenther Onkol 179:219-232
46. Langer CJ, Ruffer J, Rhodes H, Paulus R, Murray K, Movsas B, Curran W (2001) Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51:113-119 (Pubitemid 32758870)
47. Walter KA, Cahan MA, Gur A, Tyler B, Hilton J, Colvin OM, Burger PC, Domb A, Brem H (1994) Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res 54:2207-2212 (Pubitemid 24138696)
48. Korystov YN, Shaposhnikova VV, Korystova AF, Emel'yanov MO, Kublik LN (2008) Modification of multidrug resistance of tumor cells by ionizing radiation. Cancer Chemother Pharmacol 61:15-21
49. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760
50. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, Maclennan S, Baraldi PG, Borea PA (2007) Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phos-phorylation of bad in glioblastoma cells. Mol Pharmacol 72: 162-172 (Pubitemid 46998535)
51. Beduneau A, Saulnier P, Hindre F, Clavreul A, Leroux JC, Benoit JP (2007) Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Biomaterials 28:4978-4990 (Pubitemid 47371148)